Education
About Us
Working with TipRanks
Follow Us
Zhongzhi Pharmaceutical Holdings Limited (HK:3737)
:3737
3737 Stock Chart & Stats
HK$0.61
HK$0.04(4.04%)
At close: 4:00 PM EST
HK$0.61
HK$0.04(4.04%)
Day’s Range― - ―
52-Week RangeHK$0.54 - HK$1.07
Previous CloseN/A
Volume157.00K
Average Volume (3M)412.77K
Market Cap
HK$516.67M
Enterprise ValueHK$868.30M
Total Cash (Recent Filing)HK$176.31M
Total Debt (Recent Filing)HK$139.50M
Price to Earnings (P/E)23.2
Beta0.15
Next Earnings
Mar 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield8.47%
Share Statistics
EPS (TTM)0.01
Shares Outstanding863,600,000
10 Day Avg. Volume391,300
30 Day Avg. Volume412,766
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)0.70
Price to Sales (P/S)0.35
P/FCF Ratio19.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Zhongzhi Pharmaceutical Holdings Limited News
3737 FAQ
What was Zhongzhi Pharmaceutical Holdings Limited’s price range in the past 12 months?
Zhongzhi Pharmaceutical Holdings Limited lowest stock price was HK$0.54 and its highest was HK$1.07 in the past 12 months.
What is Zhongzhi Pharmaceutical Holdings Limited’s market cap?
Zhongzhi Pharmaceutical Holdings Limited’s market cap is HK$516.67M.
When is Zhongzhi Pharmaceutical Holdings Limited’s upcoming earnings report date?
Zhongzhi Pharmaceutical Holdings Limited’s upcoming earnings report date is Mar 19, 2026 which is in 92 days.
How were Zhongzhi Pharmaceutical Holdings Limited’s earnings last quarter?
Zhongzhi Pharmaceutical Holdings Limited released its earnings results on Aug 26, 2025. The company reported HK$0.011 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.011.
Is Zhongzhi Pharmaceutical Holdings Limited overvalued?
According to Wall Street analysts Zhongzhi Pharmaceutical Holdings Limited’s price is currently Overvalued.
Does Zhongzhi Pharmaceutical Holdings Limited pay dividends?
Zhongzhi Pharmaceutical Holdings Limited pays a Annually dividend of HK$0.05 which represents an annual dividend yield of 8.47%. See more information on Zhongzhi Pharmaceutical Holdings Limited dividends here
What is Zhongzhi Pharmaceutical Holdings Limited’s EPS estimate?
Zhongzhi Pharmaceutical Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zhongzhi Pharmaceutical Holdings Limited have?
Zhongzhi Pharmaceutical Holdings Limited has 863,600,000 shares outstanding.
What happened to Zhongzhi Pharmaceutical Holdings Limited’s price movement after its last earnings report?
Zhongzhi Pharmaceutical Holdings Limited reported an EPS of HK$0.011 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.22%.
Which hedge fund is a major shareholder of Zhongzhi Pharmaceutical Holdings Limited?
Currently, no hedge funds are holding shares in HK:3737
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zhongzhi Pharmaceutical Holdings Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.77%
12-Months-Change
Fundamentals
Return on Equity
1.87%
Trailing 12-Months
Asset Growth
-4.21%
Trailing 12-Months
Company Description
Zhongzhi Pharmaceutical Holdings Limited
Zhongzhi Pharmaceutical Holdings Limited (3737) is a Hong Kong-based company engaged primarily in the research, development, manufacturing, and distribution of pharmaceutical products. The company operates in various sectors within the pharmaceutical industry, including traditional Chinese medicine, Western pharmaceuticals, and healthcare products. Zhongzhi focuses on creating innovative therapeutic solutions, with a portfolio that includes prescription medications, over-the-counter drugs, and dietary supplements aimed at improving health outcomes.
Technical Analysis
Wai Yuen Tong Medicine Holdings Limited
―
Lee's Pharmaceutical Holdings Limited
―
PuraPharm Corp. Ltd.
―
Fusen Pharmaceutical Co., Ltd.
―
Pak Fah Yeow International Limited
―
Options Prices
Currently, No data available
---